InvestorsHub Logo
Followers 0
Posts 112
Boards Moderated 0
Alias Born 11/30/2006

Re: fred the cpa post# 2270

Saturday, 07/16/2011 4:08:41 PM

Saturday, July 16, 2011 4:08:41 PM

Post# of 2378
Hi Fred, I couldn't find the article in English either. But I can't think, or find any other reason they would spin this off, with the parent company (Champions) having a minority stake. Especially with Battery Ventures and more importantly Scott Tobin,(who heads the Israeli Office for Battery)on board with a substantial investment in the parent company.

Champions is protecting this Asset. If Champions get bought out, the buyer gets a minority stake in the new company. So essentially they are buying the TOS business and Personalized Oncology business, yet Sidransky and whom ever else is involved in the spinoff, retains a majority stake in the drug. Where the Real Money is.

It could simply be an Incubator Company as well. But this drug is going into Clinical Trials. As I said in a previous post, one of the biggest Pharma's in the world has a drug already on the market to target this specific cancer. If this drug comes to fruition, it will be better, much better.

Maybe I'm reading to much into this, but with the lack of disclosure, something is up.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CSBR News